Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

Radnor, Pennsylvania--(Newsfile Corp. - March 5, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover") investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or acquired Clover publicly traded securities between October 6, 2020 and February 4, 2021, inclusive (the "Class Period"), and/or purchased or acquired Clover securities pursuant or traceable to Clover's registration statement...

Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Clover Health Investments, Corp. Investors of Securities Fraud Class Action Lawsuit

San Francisco, California--(Newsfile Corp. - March 5, 2021) - Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now. A securities fraud class action has been filed and certain investors may have valuable claims.Class Period: Oct. 6, 2020 - Feb. 3, 2021Lead Plaintiff Deadline: Apr. 6, 2021Visit: www.hbsslaw.com/investor-fraud/CLOVContact An Attorney Now: CLOV@hbsslaw.com844-916-0895Clover Health Investments, Corp. (CLOV) Securities Class Action:The Complaint alleges that, through

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Clover Health Investments (CLOV) Investors with Losses to Contact its Attorneys, Investor Fraud Lawsuit Filed and Deadline Approaching

NASHVILLE, Tenn. and BOSTON , March 04, 2021 (GLOBE NEWSWIRE) -- Today, Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover”), an innovative technology company improving health outcomes for America's seniors, announced it is part of a team that received a five-year grant from the National Institutes of Health (NIH) to conduct a clinical study with researchers from Massachusetts General Hospital , Harvard Medical School and ACP Decisions , a non-profit foundation focused on advanced care planning. The study focuses on the effectiveness of multimedia tools for improving advance care planning among patients with life-limiting illness receiving home-based primary care.

Clover Health, Mass. General, and ACP Decisions Research Team Secures Grant from National Institute of Health for Innovative Approach to Advance Care Planning

A short-seller asks questions about the company's business.

Why Clover Health Stock Fell in February

RADNOR, Pa., March 04, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against Clover on behalf of those who purchased or acquired Clover publicly traded securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”), and/or purchased or acquired Clover securities pursuant or traceable to Clover's registration statement and prospectus issued in connection with the December 2020 Merger.

Kessler Topaz Meltzer & Check, LLP – Deadline Reminder for Clover Health Investments, Corp. Class Action Lawsuit

FuboTV

Invesco QQQ

AT&T

The QQQ ETF, FuboTV, Clover Health and AT&T were our top stock trades for Thursday. Let's look at the charts to see what's going on.

4 Top Stock Trades for Thursday: QQQ, FUBO, CLOV, T

San Francisco, California--(Newsfile Corp. - March 3, 2021) -  Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now. A securities fraud class action has been filed and certain investors may have valuable claims.Class Period: Oct. 6, 2020 - Feb. 3, 2021Lead Plaintiff Deadline: Apr. 6, 2021Visit: www.hbsslaw.com/investor-fraud/CLOV Contact An Attorney Now: CLOV@hbsslaw.com 844-916-0895Clover Health Investments, Corp. (CLOV) Securities Class Action:The...

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites Clover Health Investments (CLOV) Investors with Losses to Contact its Attorneys, Securities Class Action Filed

NASHVILLE, Tenn., March 03, 2021 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), an innovative technology company improving health outcomes for America's seniors, today announced that company executives will present at the Barclays Global Healthcare Conference on Wednesday, March 10 at 10:55 a.m. Eastern Time.

Clover Health to Attend the Barclays Global Healthcare Conference on March 10, 2021

BOSTON, March 03, 2021 (GLOBE NEWSWIRE) -- The law firm of Vita Law Offices, P.C. announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover”) on behalf of those who purchased or acquired Clover publicly traded securities  between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”), and/or purchased or acquired Clover securities pursuant or traceable to Clover's registration statement and prospectus issued in connection with the December 2020 Merger.

Important Deadline Reminder: Vita Law Offices P.C. Reminds Clover Health Investments, Corp. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

Radnor, Pennsylvania--(Newsfile Corp. - March 2, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover") investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or acquired Clover publicly traded securities between October 6, 2020 and February 4, 2021, inclusive (the "Class Period"), and/or purchased or acquired Clover securities pursuant or traceable to Clover's registration...

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Clover Health Investments, Corp.

The company's guidance for 2021 was below expectations.

Why Clover Health Stock Tumbled Today

A slight earnings miss is one thing, but inquiries by the DOJ and SEC, plus a flurry of class action lawsuits, mean the pressure is on for Clover Health stock. The post CLOV Stock: 2 Big Reasons Clover Health Is Plummeting Today appeared first on InvestorPlace.

CLOV Stock: 2 Big Reasons Clover Health Is Plummeting Today

The Fools discuss one of today's most controversial health companies.

Is Clover Health a Disruptor or Distractor?

Clover Health is under fire from short seller Hindenburg Research, sending CLOV stock careening toward the ground. But that's not the only factor to consider regarding the embattled organization.

It's Not Just the Allegations That Hurt Clover Health

Clover Health Investments' (CLOV) CEO Vivek Garipalli on Q4 2020 Results - Earnings Call Transcript

The Medicare Advantage insurer is looking to expand into direct contracting as a way to boost its business in 2021, but is waiting for federal approval.

Clover Health Hit By Rising Covid-19 Costs In Fourth Quarter

SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now. A securities fraud class action has been filed and certain investors may have valuable claims.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites Clover Health Investments (CLOV) Investors with Losses to Contact its Attorneys, Securities Fraud Lawsuit Filed

Grew total revenue 46% year-over-year to $673 million in 2020

Clover Health Reports Full Year 2020 Financial Results

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III ("Clover Health" or the "Company") (NASDAQ: CLOV, CLOVW) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Clover securities (1) between October 6, 2020 and February 4, 2021, both dates inclusive (the "Class Period")

CLOV Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Clover Health Investments, Corp. Investors of Class Action and Encourages Shareholders to Contact the Firm

RADNOR, Pa., Feb. 28, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover”) on behalf of those who purchased or acquired Clover publicly traded securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”), and/or purchased or acquired Clover securities pursuant or traceable to Clover's registration statement and prospectus issued in connection with the December 2020 Merger.

Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Clover Health Investments, Corp. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

San Francisco, California--(Newsfile Corp. - February 26, 2021) - Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now. A securities fraud class action has been filed and certain investors may have valuable claims.Class Period: Oct. 6, 2020 - Feb. 3, 2021Lead Plaintiff Deadline: Apr. 6, 2021Visit: www.hbsslaw.com/investor-fraud/CLOVContact An Attorney Now: CLOV@hbsslaw.com844-916-0895Clover Health Investments, Corp. (CLOV) Securities Class Action:The Complaint alleges that, thro

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites Clover Health Investments (CLOV) Investors with Losses to Contact its Attorneys, Securities Class Action Filed and Important Deadline Approaching

Radnor, Pennsylvania--(Newsfile Corp. - February 26, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover") on behalf of those who purchased or acquired Clover publicly traded securities between October 6, 2020 and February 4, 2021, inclusive (the "Class Period"), and/or purchased or acquired Clover securities pursuant or traceable to Clover's registration...

Kessler Topaz Meltzer & Check, LLP Reminds Clover Health Investments, Corp. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

Social Capital Hedosophia Holdings Corp. III

NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 merger of Clover and Social Capital III of the important April 6, 2021 lead plaintiff deadline.

ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III Investors to Secure Counsel Before Important Deadline – CLOV, CLOVW, IPOC

NEW YORK--(BUSINESS WIRE)---- $CLOV--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Tennessee on behalf of those who acquired Clover Health Investments, Corp. (“Clover” or the “Company”) (NASDAQ: CLOV) securities from October 6, 2020 through February 3, 2021 (the “Class Period”). Investors have until April 6, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. On January 7, 202

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Clover Health Investments, Corp. and Encourages Investors to Contact the Firm Before April 6, 2021

Given the allegations by Hindenburg against Clover, CLOV stock is far too risky to buy or hold at this point. The post The Allegations Against Clover Make CLOV Stock Too Risky Right Here appeared first on InvestorPlace.

News for Clover Health Investments Stock (CLOV)